home.social

#amgen — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #amgen, aggregated by home.social.

  1. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS.
    Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  2. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS.
    Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  3. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS.
    Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  4. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS.
    Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  5. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS.
    Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  6. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS. Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  7. The #avacopan story in #ANCA vasculitis is messy. IMHO #Amgen should be forced to withdraw & do another registrational trial. If not, they should be forced to do a PASS under a REMS. Finally was ava rolled out in Japan during a high #covid period -> VBS was due to virus+/-drug?

  8. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  9. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  10. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  11. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  12. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  13. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  14. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  15. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  16. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  17. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  18. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  19. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  20. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty